BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30629247)

  • 1. Improving Estrogenic Compound Screening Efficiency by Using Self-Modulating, Continuously Bioluminescent Human Cell Bioreporters Expressing a Synthetic Luciferase.
    Xu T; Kirkpatrick A; Toperzer J; Ripp S; Close D
    Toxicol Sci; 2019 Apr; 168(2):551-560. PubMed ID: 30629247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a humanized viral 2A-mediated lux operon efficiently generates autonomous bioluminescence in human cells.
    Xu T; Ripp S; Sayler GS; Close DM
    PLoS One; 2014; 9(5):e96347. PubMed ID: 24788811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Analysis of Endocrine-Disrupting Compounds Using BLYES and BLYAS Bioluminescent Yeast Bioassays.
    Xu T; Young A; Narula J; Sayler G; Ripp S
    Methods Mol Biol; 2020; 2081():29-41. PubMed ID: 31721116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for androgen agonists using autonomously bioluminescent HEK293 reporter cells.
    Xu T; Gilliam M; Sayler G; Ripp S; Close D
    Biotechniques; 2021 Aug; 71(2):403-415. PubMed ID: 34350768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Saccharomyces cerevisiae BLYES expressing bacterial bioluminescence for rapid, sensitive detection of estrogenic compounds.
    Sanseverino J; Gupta RK; Layton AC; Patterson SS; Ripp SA; Saidak L; Simpson ML; Schultz TW; Sayler GS
    Appl Environ Microbiol; 2005 Aug; 71(8):4455-60. PubMed ID: 16085836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of potentially hormonally active chemicals using bioluminescent yeast bioreporters.
    Sanseverino J; Eldridge ML; Layton AC; Easter JP; Yarbrough J; Schultz TW; Sayler GS
    Toxicol Sci; 2009 Jan; 107(1):122-34. PubMed ID: 18996888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AroER tri-screen is a biologically relevant assay for endocrine disrupting chemicals modulating the activity of aromatase and/or the estrogen receptor.
    Chen S; Zhou D; Hsin LY; Kanaya N; Wong C; Yip R; Sakamuru S; Xia M; Yuan YC; Witt K; Teng C
    Toxicol Sci; 2014 May; 139(1):198-209. PubMed ID: 24496634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of zebrafish estrogen receptor subtypes by chemicals by using stable reporter gene assay developed in a zebrafish liver cell line.
    Cosnefroy A; Brion F; Maillot-Maréchal E; Porcher JM; Pakdel F; Balaguer P; Aït-Aïssa S
    Toxicol Sci; 2012 Feb; 125(2):439-49. PubMed ID: 22045033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a recombinant human ovarian (BG1) cell line containing estrogen receptor α and β for improved detection of estrogenic/antiestrogenic chemicals.
    Brennan JC; Bassal A; He G; Denison MS
    Environ Toxicol Chem; 2016 Jan; 35(1):91-100. PubMed ID: 26139245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous, real-time bioimaging of chemical bioavailability and toxicology using autonomously bioluminescent human cell lines.
    Xu T; Close DM; Webb JD; Price SL; Ripp SA; Sayler GS
    Proc SPIE Int Soc Opt Eng; 2013 May; 8723():872310. PubMed ID: 26516295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of the bacterial luciferase gene cassette (lux) as a real-time bioreporter.
    Close D; Xu T; Smartt A; Rogers A; Crossley R; Price S; Ripp S; Sayler G
    Sensors (Basel); 2012; 12(1):732-52. PubMed ID: 22368493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an imaging-based in vitro screening platform for estrogenic activity with OECD reference chemicals.
    Duijndam B; Tedeschi M; van der Stel W; van den Hoorn T; van der Burg B; Bouwman P; van der Laan JW; van de Water B
    Toxicol In Vitro; 2022 Jun; 81():105348. PubMed ID: 35307500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine-Disrupting Chemicals (EDCs): In Vitro Mechanism of Estrogenic Activation and Differential Effects on ER Target Genes.
    Li Y; Luh CJ; Burns KA; Arao Y; Jiang Z; Teng CT; Tice RR; Korach KS
    Environ Health Perspect; 2013 Apr; 121(4):459-66. PubMed ID: 23384675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integral assessment of estrogenic potentials in sediment-associated samples: Part 2: Study of estrogen and anti-estrogen receptor-binding potentials of sediment-associated chemicals under different salinity conditions using the salinity-adapted enzyme-linked receptor assay.
    Kase R; Hansen PD; Fischer B; Manz W; Heininger P; Reifferscheid G
    Environ Sci Pollut Res Int; 2009 Jan; 16(1):54-64. PubMed ID: 19011916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.
    LeBaron MJ; Coady KK; O'Connor JC; Nabb DL; Markell LK; Snajdr S; Sue Marty M
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):23-42. PubMed ID: 24515815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prêt-à-porter nanoYESα and nanoYESβ bioluminescent cell biosensors for ultrarapid and sensitive screening of endocrine-disrupting chemicals.
    Lopreside A; Calabretta MM; Montali L; Ferri M; Tassoni A; Branchini BR; Southworth T; D'Elia M; Roda A; Michelini E
    Anal Bioanal Chem; 2019 Jul; 411(19):4937-4949. PubMed ID: 30972468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choriogenin transcription in medaka embryos and larvae as an alternative model for screening estrogenic endocrine-disrupting chemicals.
    Ishibashi H; Uchida M; Temma Y; Hirano M; Tominaga N; Arizono K
    Ecotoxicol Environ Saf; 2020 Apr; 193():110324. PubMed ID: 32088548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the endocrine-disrupting effects of short-chain chlorinated paraffins in in vitro models.
    Zhang Q; Wang J; Zhu J; Liu J; Zhang J; Zhao M
    Environ Int; 2016 Sep; 94():43-50. PubMed ID: 27208783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid and reagent-free bioassay for the detection of dioxin-like compounds and other aryl hydrocarbon receptor (AhR) agonists using autobioluminescent yeast.
    Xu T; Young A; Marr E; Sayler G; Ripp S; Close D
    Anal Bioanal Chem; 2018 Feb; 410(4):1247-1256. PubMed ID: 29214529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of endocrine disrupting chemicals with MELN cells, an ER-transactivation assay combined with cytotoxicity assessment.
    Berckmans P; Leppens H; Vangenechten C; Witters H
    Toxicol In Vitro; 2007 Oct; 21(7):1262-7. PubMed ID: 17572059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.